In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients

Peptide vaccines derived from tumour-associated antigens have been used as an immunotherapeutic approach to induce specific cytotoxic immune response against tumour. We previously identified that MAGED4B and FJX1 proteins are overexpressed in HNSCC patients; and further demonstrated that two HLA-A2-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Main Authors: Chai, San Jiun, Fong, Sammuel Chee Yong, Gan, Chai Phei, Pua, Kin Choo, Lim, Paul Vey Hong, Lau, Shin Hin, Zain, Rosnah Binti, Abraham, Thomas, Ismail, Siti Mazlipah, Abdul Rahman, Zainal Ariff, Ponniah, Sathibalan, Patel, Vyomesh, Cheong, Sok Ching, Lim, Kue Peng
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6363157/
https://ncbi.nlm.nih.gov/pubmed/30193086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1520584
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares